← Leaderboards
Joseph Carson
Pensievision, Inc.
$2,558,876
Attributed
$2,558,876
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2021–24$2M$1.5M$1M$500K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$2,558,876 · 2
By mechanism
R44$2,158,876 · 1
R43$400,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Diagnosis”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$337,858,596
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$141,100,782
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Leonard Freedmand · Leidos Biomedical Research, Inc.$66,248,714
Research focus
DiagnosisHealth Care CostsDeveloped CountriesDevicesFollow-UpHeadCostCountryComputer SoftwareDeveloping CountriesAwardEligibility DeterminationCancer CareFutureAfrica South Of The SaharaColposcopy3-DimensionalColorCervical Cancer PreventionAdvocateCervix NeoplasmsAreaCessation Of LifeHigh Resolution Imaging
Grant awards (3)
A Novel, Low-Cost, Handheld, 3D Imaging System for Improved Screening of Cervical Neoplasia in Resource Limited Settings$1,041,955
R44 · FY2024 · CA · contact PI
A Novel, Low-Cost, Handheld, 3D Imaging System for Improved Screening of Cervical Neoplasia in Resource Limited Settings$1,116,921
R44 · FY2023 · CA · contact PI
A Novel, Low-Cost, Handheld, 3D Imaging System for Improved Screening of Cervical Neoplasia in Resource Limited Settings$400,000
R43 · FY2021 · CA · contact PI